Evidence map›Paper›PMID 39874873›Full record

ArticleCancer genetics2025

In silico protein structural analysis of PRMT5 and RUVBL1 mutations arising in human cancers.

Majd Al-Marrawi, Ruben C Petreaca, Renee A Bouley

Abstract read
In one paragraph

Article in Cancer genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Majd Al-MarrawiNeuroscience Undergraduate Program, The Ohio State University, USA.
Ruben C PetreacaDepartment of Molecular Genetics, The Ohio State University, Marion, USA; Cancer Biology, The James Comprehensive Cancer Center, The Ohio State University, Columbus, USA.
Renee A BouleyDepartment of Chemistry and Biochemistry, The Ohio State University, Marion, USA. Electronic address: bouley.8@osu.edu.

Funding

The role of PRMT5 in preventing intra-chromosomal deletions in cancer cellsR03CA276967 · NCI · OHIO STATE UNIVERSITY · PI BOULEY, RENEE, PETREACA, RUBEN CIPRIAN · 2023 to 2024
$158k
NCI NIH HHS R03 CA276967
6 · The paper itself

Abstract

DNA double strand breaks (DSBs) can be generated spontaneously during DNA replication and are repaired primarily by Homologous Recombination (HR). However, efficient repair requires chromatin remodeling to allow the recombination machinery access to the break. TIP60 is a complex conserved from yeast to humans that is required for histone acetylation and modulation of HR activity at DSBs. Two enzymatic activities within the TIP60 complex, KAT5 (a histone acetyltransferase) and RUVBL1 (an AAA+ ATPase) are required for efficient HR repair. Post-translational modification of RUVBL1 by the PRMT5 methyltransferase activates the complex acetyltransferase activity and facilitates error free HR repair. In S. pombe a direct interaction between PRMT5 and the acetyltransferase subunit of the TIP60 complex (KAT5) was also identified. The TIP60 complex has been partially solved experimentally in both humans and S. cerevisiae, but not S. pombe. Here, we used in silico protein structure analysis to investigate structural conservation between S. pombe and human PRMT5 and RUVBL1. We found that there is more similarity in structure conservation between S. pombe and human proteins than between S. cerevisiae and human. Next, we queried the COSMIC database to analyze how mutations occurring in human cancers affect the structure and function of these proteins. Artificial intelligence algorithms that predict how likely mutations are to promote cellular transformation and immortalization show that RUVBL1 mutations should have a more drastic effect than PRMT5. Indeed, in silico protein structural analysis shows that PRMT5 mutations are less likely to destabilize enzyme function. Conversely, most RUVBL1 mutations occur in a region required for interaction with its partner (RUVBL2). These data suggests that cancer mutations could destabilize the TIP60 complex. Sequence conservation analysis between S. pombe and humans shows that the residues identified in cancer cells are highly conserved, suggesting that this may be an essential process in eukaryotic DSB repair. These results shed light on mechanisms of DSB repair and also highlight how S. pombe remains a great model system for analyzing DSB repair processes that are tractable in human cells.

Indexed as

Carrier ProteinsDNA HelicasesMutationNeoplasmsProtein-Arginine N-MethyltransferasesAmino Acid SequenceATPases Associated with Diverse Cellular ActivitiesComputer SimulationHistone AcetyltransferasesHumansLysine Acetyltransferase 5Models, MolecularSchizosaccharomycesATPases Associated with Diverse Cellular ActivitiesCarrier ProteinsDNA HelicasesHistone AcetyltransferasesKAT5 protein, humanLysine Acetyltransferase 5PRMT5 protein, humanProtein-Arginine N-MethyltransferasesRUVBL1 protein, humanCancer geneticsChromatin remodelingDNA damageMutationProtein structural analysis

Identifiers

PMID39874873
PMCPMC12395466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.